Founder and Executive VP of RandDDr. Yoseph Shaaltiel, Ph.D., is Executive Vice President Research Development, Director of Protalix BioTherapeutics Inc. Dr. Shaaltiel founded Protalix Ltd. in 1993. He has served as a member of Board of Directors and as Vice President, Research and Development since December 31, 2006. Prior to establishing Protalix Ltd., from 1988 to 1993, Dr. Shaaltiel was a Research Associate at the MIGAL Technological Center. He also served as Deputy Head of the Biology Department of the Biological and Chemical Center of the Israeli Defense Forces and as a Biochemist at Makor Chemicals Ltd. Dr. Shaaltiel was a Postdoctoral Fellow at the University of California at Berkeley and at Rutgers University in New Jersey. He has coauthored over 40 articles and abstracts on plant biochemistry and holds seven patents
Age: 60 Founder Since 2008 Ph.DShaaltiel received his Ph.D. in Plant Biochemistry from the Weizmann Institute of Science, an M.Sc. in Biochemistry from the Hebrew University and a B.Sc. in Biology from the Ben Gurion University.